Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bader, Michael Prof. Dr. (8) Bähring, Sylvia Dr. (5) Birchmeier, Walter Prof. Dr. (5) Birchmeier-Kohler, Carmen Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (9) Dechend, Ralf Priv. Doz. (4) Falcke, Martin Prof. Dr. (2) Fielitz, Jens Dr. (1) Gerhardt, Holger Prof. Dr. (1) Gotthardt, Michael Prof. Dr. (1) Höpken, Uta Elisabeth PD Dr. (2) Hübner, Norbert Prof. Dr. (5) Ivics, Zoltan Dr. (3) Izsvak, Zsuzsanna Dr. (4) Jentsch, Thomas Prof. Dr. (12) Kettenmann, Helmut Prof. Dr. (15) Kettritz, Ralph Prof. Dr. (1) Klußmann, Enno PD Dr. (2) Kocks, Christine Dr. (1) Kühn, Ralf Dr. (5) Lee, Young-Ae Prof. Dr. (2) Leutz, Achim Prof. Dr. (4) Lewin, Gary Prof. Dr. (5) Luft, Friedrich Prof. Dr. (53) Morano, Ingo Prof. Dr. (11) Müller, Dominik Prof. Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Rahn, Hans-Peter Dr. (1) Rajewsky, Klaus Prof. Dr. (2) Rajewsky, Nikolaus Prof. Dr. (1) Rathjen, Fritz Prof. Dr. (1) Sander, Maike Prof. Dr. (2) Spuler, Simone Prof. (3) Walther, Wolfgang Prof. Dr. (7) Wanker, Erich Prof. Dr. (4) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (4) Wolf, Jana Prof. Dr. (2) (-) Scheidereit, Claus Prof. Dr. (4) (-) Stein, Ulrike Prof. Dr. (7) Translationale Onkologie solider Tumore (7) 1991 (1) 1992 (3) 1993 (5) 1994 (10) 1995 (1) 1996 (13) (-) 1997 (11) 1998 (10) 1999 (9) 2000 (17) 2001 (12) 2002 (20) 2003 (15) 2004 (17) 2005 (18) 2006 (22) 2007 (16) 2009 (21) 2010 (17) 2011 (18) 2012 (21) 2013 (22) 2014 (17) 2015 (18) 2016 (25) 2017 (19) 2018 (16) 2019 (17) 2020 (29) 2021 (33) 2022 (26) 2023 (19) 2024 (9) 11 Ergebnisse: Active Filter: Scheidereit, Claus Prof. Dr.Stein, Ulrike Prof. Dr.1997 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1997 / Hum Genet The role of oxygen metabolism for the pathological phenotype of fanconi anemia W. Ruppitsch C. Meisslitzer H. Weirichschwaiger H. Klocker C. Scheidereit M. Schweiger M. Hirschkauffmann 01. Januar 1997 / Biotechniques In situ RT-PCR using fluorescence-labeled primers U. Stein W. Walther J. Wendt T.A. Schild 01. Januar 1997 / J Natl Cancer Inst Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP U. Stein W. Walther C.M. Laurencot G.L. Scheffer R.J. Scheper R.H. Shoemaker 01. Januar 1997 / Int J Cancer Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo U. Stein W. Walther M. Lemm H. Naundorf I. Fichtner 01. Januar 1997 / Gene Ther Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy W. Walther J. Wendt U. Stein 01. Januar 1997 / Proc Am Assoc Cancer Res Diverse effects of tumor necrosis factor a on expression of the multidrug resistance-associated genes LRP and MRP U. Stein W. Walther C.M. Laurencot G.L. Scheffer R.J. Scheper R.H. Shoemaker 01. Januar 1997 / Proc Am Assoc Cancer Res Development and characterization of novel multidrug resistant breast cancer lines W. Walther U. Stein M. Lemm H. Naundorf I. Fichtner 01. Januar 1997 Modulation of MDR1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug U. Stein W. Walther R.H. Shoemaker 15. Oktober 1997 / Nucleic Acids Res Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site M.R. Pelletier E.N. Hatada G. Scholz C. Scheidereit 15. Dezember 1997 / J Clin Invest Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells R.C. Bargou F. Emmerich D. Krappmann K. Bommert M.Y. Mapara W. Arnold H.D. Royer E. Grinstein A. Greiner C. Scheidereit B. Doerken Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Januar 1997 / Hum Genet The role of oxygen metabolism for the pathological phenotype of fanconi anemia W. Ruppitsch C. Meisslitzer H. Weirichschwaiger H. Klocker C. Scheidereit M. Schweiger M. Hirschkauffmann
01. Januar 1997 / Biotechniques In situ RT-PCR using fluorescence-labeled primers U. Stein W. Walther J. Wendt T.A. Schild
01. Januar 1997 / J Natl Cancer Inst Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP U. Stein W. Walther C.M. Laurencot G.L. Scheffer R.J. Scheper R.H. Shoemaker
01. Januar 1997 / Int J Cancer Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo U. Stein W. Walther M. Lemm H. Naundorf I. Fichtner
01. Januar 1997 / Gene Ther Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy W. Walther J. Wendt U. Stein
01. Januar 1997 / Proc Am Assoc Cancer Res Diverse effects of tumor necrosis factor a on expression of the multidrug resistance-associated genes LRP and MRP U. Stein W. Walther C.M. Laurencot G.L. Scheffer R.J. Scheper R.H. Shoemaker
01. Januar 1997 / Proc Am Assoc Cancer Res Development and characterization of novel multidrug resistant breast cancer lines W. Walther U. Stein M. Lemm H. Naundorf I. Fichtner
01. Januar 1997 Modulation of MDR1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug U. Stein W. Walther R.H. Shoemaker
15. Oktober 1997 / Nucleic Acids Res Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site M.R. Pelletier E.N. Hatada G. Scholz C. Scheidereit
15. Dezember 1997 / J Clin Invest Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells R.C. Bargou F. Emmerich D. Krappmann K. Bommert M.Y. Mapara W. Arnold H.D. Royer E. Grinstein A. Greiner C. Scheidereit B. Doerken